4th EUFEMED Conference
25-26 May 2023 - Berlin (Germany)
Menü
Mastering the New Time Pressure on Human Pharmacology
Focused strategies based on lessons learned in the pandemic
25-26 May 2023 - Berlin (Germany)
Mastering the New Time Pressure on Human Pharmacology
Focused strategies based on lessons learned in the pandemic
status of 05/2023, in alphabetical order
Tabletop Presentation
Merck Sharp & Dohme, Rahway, NJ, USA – Grant of $ 5,000.00
Sponsorship 2.200 €
In accordance with the recommendations of the German Medical Association (Bundesärztekammer), the Association of Scientific Medical Societies (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften) and the Voluntary Self-Regulation Body for the Pharmaceutical Industry (Freiwilliger Selbstkontrolle für die Arzneimittelindustrie e. V.), §20 para. 5. (FSA Codex Professionals, §20 para. 5), the contributions (amounts stated are net, before deduction of costs) of the industry partners are disclosed. The named companies participate in the 3rd EUFEMED in the exchange of services.
ARENSIA Exploratory Medicine GmbH · 1,000 €
Biokinetica S. A. · 4,800 €
CRS Clinical Research Services Management GmbH · 1,500 €
CTC North GmbH & Co. KG · 1,000 €
Eurofins Optimed · 3,500 €
SGS Belgium NV · 1,500 €
SocraTec R&D GmbH · 1,500 €
Syndesi Therapeutics SA · 1,500 €
Amounts net, before deduction of costs.
Status: October 2022
CSi Hamburg GmbH
Goernestraße 30
20249 Hamburg (Germany)
